logo
Products
Services
Resources
Selection Guides
About
mFluor™ Violet 540 Anti-human CD267 Antibody
1A1
The 1A1 monoclonal antibody binds with human CD267, a 32 kD single-pass type iii membrane protein typically found on the surface of meyloma cells and B cells. CD267 is a component of important cellular pathways, namely, the tumor necrosis factor-mediated signaling pathway and cell surface receptor signaling pathway. Also, in some organisms, it is a suppressor of B cell proliferation. From a research standpoint, it is of biological interest due to its association with important macromolecules/ligands like BAFF, BLYS and TALL1. CD267 is a relatively rare antibody target, with fewer than 50 publications in the last decade. Even still, CD267 has been widely used in costimulatory molecules and immunology research, frequently serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to mFluor™ Violet 540 (ex/em = 394/537 nm). It is compatible with the 405 nm laser and 530/30 nm bandpass filter (for example, as in the Agilent Technologies NovoCyte).
product image
product image
CatalogSize
Price
Quantity
12670120100 tests
Price
12670121500 tests
Price
 
Antibody properties

Other namesTACI, TNFRSF13B
Clone1A1
HostN/a
IsotypeN/A
ReactivityHuman
ApplicationFlow Cytometry (FACS), Fluorescence Imaging
Spectral properties

Absorbance (nm)401
Correction factor (260 nm)1.326
Correction factor (280 nm)0.543
Extinction coefficient (cm -1 M -1)
18000
1
Excitation (nm)402
Emission (nm)535
Quantum yield
0.21
1
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on February 16, 2026